Clinical Trial: Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Brief Summary: The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.

Detailed Summary:
Sponsor: Novartis Pharmaceuticals

Current Primary Outcome:

  • Change in cognition from baseline at week 24
  • Global clinical impression of change from baseline at week 24


Original Primary Outcome:

Current Secondary Outcome:

  • Change in activities of daily living from baseline at week 24
  • Change in behavioral symptoms from baseline at week 24
  • Change in clinical staging from baseline at week 24


Original Secondary Outcome:

Information By: Novartis

Dates:
Date Received: December 10, 2004
Date Started: August 2001
Date Completion:
Last Updated: November 16, 2011
Last Verified: November 2011